Commitment to innovation, excellence, equity, and inclusivity

The Dymecki Lab embraces the core mission of Harvard Medical School, which is to alleviate human suffering by nurturing a diverse group of leaders and future leaders in biomedical inquiry.  Dymecki is dedicated to ensuring excellence in scientific training, innovativeness in experimental approach, and accessibility to tools, reagents, and results. Inclusivity and equity define the lab culture.


  • Read the recent publication featuring Olga Alekseenko's work in "Serotonergic Modulation of Aggression in Drosophila Involves GABAergic and Cholinergic Opposing Pathways", now available at Current Biology.
  • The Dymecki Lab's work was featured in The New York Times article "What Causes SIDS?" by Carrie Arnold, which can be read here.
  • Our most recent review, "Embracing diversity in the 5-HT Neuronal System" is now available at Nature Reviews Neuroscience.
  • Several of our lab members attended the Society for Neuroscience Meeting in San Diego during the first week of November.
  • Our most recent paper, "Acute perturbation of Pet1-neuron activity in neonatal mice impairs cardiorespiratory homeostatic recovery," is currently available at eLife.


Specialization in the Serotonin System Shapes Behavior

and Regulates Homeostasis

The Dymecki lab studies how functional modularity arises within the brain serotonergic neuronal system and dynamically controls diverse processes ranging from respiration and thermal balance to emotional mood state to coping behaviors…

Read More